Cargando…
Sacubitril/Valsartan Therapy for 14 Months Induces a Marked Improvement of Global Longitudinal Strain in Patients With Chronic Heart Failure: A Retrospective Cohort Study
BACKGROUND: Clinical efficacy of sacubitril/valsartan administered for the recommended indication of chronic heart failure (CHF) patients with New York Heart Association (NYHA) classes II-III appears to be higher than one would expect based on the drug-induced variations of the left ventricular ejec...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elmer Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785293/ https://www.ncbi.nlm.nih.gov/pubmed/31636797 http://dx.doi.org/10.14740/cr910 |